BridgeMD
New treatment option for Post Traumatic Stress Disorder
Official title OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
ClinicalTrials.gov ID: NCT05156112
What this study is testing
- What it's testing
- Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional impairment than having either disorder alone. This is especially true in residential settings where both disorders are more severe than outpatient settings.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- a Veteran of the U.S. military or Reserve/National Guard member
- at least 18 years of age
- have an AHI 5 per hour
- experienced trauma that occurred in childhood or adulthood; at least one month post-trauma
- have current DSM-5 diagnoses of SUD via SCID-SUD module with a minimum 20 days of substance use in the last 90 days (Timeline Follow-back)
You likely can't join if
- have central sleep apnea (AHI \>=5 and \> 50% central apneas)
- arrives on the SARRTP unit already using a PAP device (Veteran's previously diagnosed with OSA, but not using PAP therapy will be eligible)
- the SARRTP medical staff advises against the study based on medical history and physical examination; d) history of severe cognitive impairment (via...
- history of psychosis or mania independent of substance use will be excluded because the presence of these disorders can impede therapy progress
See the full eligibility criteria
- a Veteran of the U.S. military or Reserve/National Guard member
- at least 18 years of age
- have an AHI 5 per hour
- experienced trauma that occurred in childhood or adulthood; at least one month post-trauma
- have current DSM-5 diagnoses of SUD via SCID-SUD module with a minimum 20 days of substance use in the last 90 days (Timeline Follow-back)
- Full PTSD diagnosis via clinician administered PTSD scale
- are literate in English
- are on the PTSD track of the SARRTP unit
- are capable of giving informed consent
- have central sleep apnea (AHI \>=5 and \> 50% central apneas)
- arrives on the SARRTP unit already using a PAP device (Veteran's previously diagnosed with OSA, but not using PAP therapy will be eligible)
- the SARRTP medical staff advises against the study based on medical history and physical examination; d) history of severe cognitive impairment (via MOCA \< 26)
- history of psychosis or mania independent of substance use will be excluded because the presence of these disorders can impede therapy progress
The study team makes the final eligibility decision.
Where it's taking place
- San Diego, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Diego, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.